Michael McCullar's guest appearances

Michael McCullar

Empowered Patient Podcast

BioTech IQ

James Mackay

Spiro Rombotis

Mike Rea

Jim Woody

Robert Foster

Seth Lederman

Thomas Cowan

James Joyce

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

OwlTail

Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer treatments. Mike also shares with us the challenges and importance of strong leadership in our evolving workforce. https://twitter.com/onquality_rxhttps://www.linkedin.com/company/onquality-pharmaceuticals-ltd/https://www.onqualityrx.com/Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/

Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer treatments. Mike also shares with us the challenges and importance of strong leadership in our evolving workforce.  <a href="https://twitter.com/onquality_rx" rel="nofollow" target="_blank">https://twitter.com/onquality_rx</a> <a href="https://www.linkedin.com/company/onquality-pharmaceuticals-ltd/" rel="nofollow" target="_blank">https://www.linkedin.com/company/onquality-pharmaceuticals-ltd/</a> <a href="https://www.onqualityrx.com/" rel="nofollow" target="_blank">https://www.onqualityrx.com/</a><a href="https://www.buzzsprout.com/1208600/support" rel="payment nofollow" target="_blank">Support the show</a>Check me out on LinkedIn <a href="https://www.linkedin.com/in/ammonr/" rel="nofollow" target="_blank">https://www.linkedin.com/in/ammonr/</a>

#23 Targeting treatment related toxicities - Michael McCullar - CEO OnQuality Pharmaceuticals

Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea.  As leaders in the emerging oncodermatology and oncogastroenterology fields, the mission is to develop cancer supportive care drugs to deal with the most common toxicities to make it easier for patients to tolerate their cancer treatments. @OnQualityRx #cancer #cancertherapy #cancerresearch #chemotherapy #supportivecare #cancertherapeutics #pharma OnQualityRx.com Download the transcript here

Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea.  As leaders in the emerging oncodermatology and oncogastroenterology fields, the mission is to develop cancer supportive care drugs to deal with the most common toxicities to make it easier for patients to tolerate their cancer treatments. @OnQualityRx #cancer #cancertherapy #cancerresearch #chemotherapy #supportivecare #cancertherapeutics #pharma <a href="http://onqualityrx.com" rel="noopener nofollow" target="_blank">OnQualityRx.com</a> <a href="http://empoweredpatientradio.com/targeted-cancer-supportive-care-agent-for-skin-toxicities-with-michael-mccullar-and-hong-tang-onquality-pharmaceuticals-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Targeted Cancer Supportive Care Agent for Skin Toxicities with Michael McCullar and Hong Tang OnQuality Pharmaceuticals